Taipan venom used as a new drug to treat heart failure A venom component from the Taipan, the world's deadliest snake, is being developed by Brisbane biotechnology company ElaCor, as a new drug to treat heart failure. Current treatments for congestive heart failure (CHF), an often-fatal dis...
Drug used to treat heart failure led to dozens of deaths
Heart failure is a global health problem commonly complicated by sleep apnea, a co-morbidity that further reduces a person’s lifespan. A promising new drug has been developed that could treat heart failure and sleep apnea by targeting the nervous activity that drives bot...
“No scar, no heart damage, no heart failure – people can survive heart attacks because the heart won’t even be damaged.”Tami Martino “This research is really exciting because it opens the door to use circadian medicine therapies to heal heart attacks after they occur and to pre...
7.Efficacy of Huoxueyixin decoction to treat chronic congestive heart failure活血益心汤治疗慢性充血性心力衰竭 8.Clinical Study of Xinshuai No.2 in the Treatment of Congestive Heart Failure;心衰2号治疗慢性充血性心力衰竭的临床研究 9.The Experimental Study on Xin Shuai He Ji to Cure Congestive Hea...
Despite considerable therapeutic advances, treatment of acute decompensated heart failure has not changed much over the past 25 years, as new drugs have failed to reduce morbidity and mortality rates compared to placebo. Furthermore, no treatment strategy has improved clinical outcomes in patients with...
Although heart failure is predominantly caused by cardiovascular conditions such as hypertension, coronary heart disease and valvular heart disease, it can also be an adverse reaction induced by drug therapy. In addition, some drugs have the propensity to adversely affect haemodynamic mechanisms in patie...
The Food and Drug Administration (FDA) has approved a novel first-in-class drug to treat type 2 diabetes. The drug is called tirzepatide. A person has it as a once-weekly injection under the skin. It has a dual effect, lowering blood sugar and supporting weight loss better than currentl...
Rifampicin and isoniazid are often used together as a co-therapy to treat tuberculosis, but their combined use often leads to hepatoxicity in humans. Xiaochao Ma and colleagues now report the mechanisms behind this side effect, thus opening a possible avenue to the safer use of these effective...
Other compounds with different spectra of kinase inhibition are currently used to treat renal cell carcinoma, non-small-cell lung cancer and colon cancer. More recently, the therapeutic potential of TKIs in non-malignant disorders has been recognized. Clinical research has progressed far in pulmonary...